Stock listing
Stella Diagnostics Inc.
Selected listing: SLDX · OTC · USD · US
Stella Diagnostics Inc. (OTC:SLDX), Health Technology. Latest release May 11, 2022: Stella Diagnostics and Mayo Clinic to Present Data on the Utility…
- Ticker
- OTC:SLDX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- OTC
- Currency
- USD
About Stella Diagnostics Inc.
The company focuses on providing innovative diagnostic solutions. As a publicly traded entity, it operates within the American market, aiming to enhance healthcare outcomes through its offerings.
Latest news from Stella Diagnostics Inc.
Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference
May 11, 2022
Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
April 22, 2022
Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting
April 6, 2022
Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting
March 2, 2022
Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards
February 16, 2022
Research Stella Diagnostics Inc.
Stella Diagnostics Inc. company profile
View the public company page for Stella Diagnostics Inc. on 6ix.
Stella Diagnostics Inc. news
Read company news and market updates connected to Stella Diagnostics Inc..
Stella Diagnostics Inc. investor events
Find investor webinars, events, and replay context for Stella Diagnostics Inc..